TLR7 and neoplasm: The authors concluded that anti‐tumor effects of R848 were mediated by host‐derived TLR7‐positive stromal cells, rather than by direct influence on neoplastic cells since the implantation of syngeneic tumor cells in TLR7−/− host mice with subsequent R848 treatment did not result in attenuated, but instead in accelerated tumor growth.